CINCINNATI, April 19, 2017, Johnson
& Johnson subsidiary Ethicon today received FDA 510(k) clearance for its Echelon circular powered stapler.
The ECHELON CIRCULAR™ Powered Stapler
is equipped with 2 new technologies that enables it to reduce leaks without compromising
circulation of the targeted organ.
Through proprietary Gripping Surface Technology,
it is better able to hold the tissues with 33% reduction is tissue trauma. The
second technology is 3D Stapling Technology which evenly distributes
compression throughout the anastomosis.
A study showed 61% fewer leaks at the
staple line compared to Medtronic's DST Series™ EEA™ Stapler.
"Ethicon is committed to reducing
complications, which have a significant impact on healthcare costs and patient
outcomes," says Tom O'Brien, Vice President, Global Endomechanical
Platform Leader.
"The ECHELON CIRCULAR™ Powered Stapler addresses these
challenges by combining powered firing with two staple forming innovations that
reduce leaks without compromising perfusion.”
The circular anastomosis is a very
decisive step for the success of cancer surgery, that already have high risk of
complications because of friability of the tissue. The most dreaded complication
is leak which can lead to repeat surgery of the patient with high morbidity and
insurance cost.
The circular stapler will specially
improve results of bariatric and colorectal,
gastric and thoracic cancer surgeries.
No comments:
Post a Comment